{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T10:03:03Z","timestamp":1792404183721,"version":"4.4.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,10]],"date-time":"2022-12-10T00:00:00Z","timestamp":1670630400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002402","name":"Sun Yat-sen University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002402","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Guangdong Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2019A050510028"],"award-info":[{"award-number":["2019A050510028"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016691","name":"Guangdong Provincial Pearl River Talents Program","doi-asserted-by":"publisher","award":["2017GC010411"],"award-info":[{"award-number":["2017GC010411"]}],"id":[{"id":"10.13039\/100016691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010096","name":"Southern Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010096","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018611","name":"International Science and Technology Cooperation Program of Shanxi Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018611","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81871270"],"award-info":[{"award-number":["81871270"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Nucleic Acids"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.omtn.2022.12.008","type":"journal-article","created":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T02:10:39Z","timestamp":1670811039000},"page":"88-104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Chemically modified small interfering RNA targeting Hedgehog signaling pathway for rheumatoid arthritis therapy"],"prefix":"10.1016","volume":"31","author":[{"given":"Lang","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shangling","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin-Ping","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianlin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2022.12.008_bib1","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","article-title":"Rheumatoid arthritis","volume":"388","author":"Smolen","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.omtn.2022.12.008_bib2","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/art.40406","article-title":"The tumor-like phenotype of rheumatoid synovium: molecular profiling and prospects for precision medicine","volume":"70","author":"You","year":"2018","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.omtn.2022.12.008_bib3","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1001\/jama.2018.13103","article-title":"Diagnosis and management of rheumatoid arthritis: a review","volume":"320","author":"Aletaha","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.omtn.2022.12.008_bib4","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/acr.24596","article-title":"2021 American College of Rheumatology guideline for the treatment of rheumatoid arthritis","volume":"73","author":"Fraenkel","year":"2021","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.omtn.2022.12.008_bib5","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nrrheum.2012.190","article-title":"Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors","volume":"9","author":"Bottini","year":"2013","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.omtn.2022.12.008_bib6","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.3389\/fimmu.2019.01395","article-title":"Regulation of immune responses and chronic inflammation by fibroblast-like synoviocytes","volume":"10","author":"Yoshitomi","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtn.2022.12.008_bib7","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/s41584-020-0413-5","article-title":"Restoring synovial homeostasis in rheumatoid arthritis by targeting fibroblast-like synoviocytes","volume":"16","author":"Nygaard","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.omtn.2022.12.008_bib8","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1101\/gad.1693608","article-title":"Hedgehog: functions and mechanisms","volume":"22","author":"Varjosalo","year":"2008","journal-title":"Genes Dev."},{"key":"10.1016\/j.omtn.2022.12.008_bib9","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/nrm3598","article-title":"The mechanisms of Hedgehog signalling and its roles in development and disease","volume":"14","author":"Briscoe","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.omtn.2022.12.008_bib10","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.phrs.2019.01.014","article-title":"Targeting Hedgehog signaling pathway: paving the road for cancer therapy","volume":"141","author":"Salaritabar","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.omtn.2022.12.008_bib11","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.tips.2009.03.007","article-title":"Mechanisms of Hedgehog pathway activation in cancer and implications for therapy","volume":"30","author":"Scales","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.omtn.2022.12.008_bib12","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s41571-019-0293-2","article-title":"Targeting signalling pathways and the immune microenvironment of cancer stem cells - a clinical update","volume":"17","author":"Clara","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.omtn.2022.12.008_bib13","doi-asserted-by":"crossref","first-page":"940455","DOI":"10.3389\/fimmu.2022.940455","article-title":"Role of the Hedgehog signaling pathway in rheumatic diseases: an overview","volume":"13","author":"Su","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtn.2022.12.008_bib14","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1056\/NEJMoa1113713","article-title":"Efficacy and safety of vismodegib in advanced basal-cell carcinoma","volume":"366","author":"Sekulic","year":"2012","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtn.2022.12.008_bib15","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S1470-2045(15)70100-2","article-title":"Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): a multicentre, randomised, double-blind phase 2 trial","volume":"16","author":"Migden","year":"2015","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.omtn.2022.12.008_bib16","doi-asserted-by":"crossref","first-page":"6021","DOI":"10.1158\/1078-0432.CCR-19-0365","article-title":"FDA approval summary: glasdegib for newly diagnosed acute myeloid leukemia","volume":"25","author":"Norsworthy","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omtn.2022.12.008_bib17","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ccell.2015.02.001","article-title":"Genomic analysis of smoothened inhibitor resistance in basal cell carcinoma","volume":"27","author":"Sharpe","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.omtn.2022.12.008_bib18","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.ccell.2015.02.002","article-title":"Smoothened variants explain the majority of drug resistance in basal cell carcinoma","volume":"27","author":"Atwood","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.omtn.2022.12.008_bib19","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41573-019-0017-4","article-title":"The current state and future directions of RNAi-based therapeutics","volume":"18","author":"Setten","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omtn.2022.12.008_bib20","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41392-020-0207-x","article-title":"Therapeutic siRNA: state of the art","volume":"5","author":"Hu","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.omtn.2022.12.008_bib21","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41573-020-0075-7","article-title":"Advances in oligonucleotide drug delivery","volume":"19","author":"Roberts","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omtn.2022.12.008_bib22","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/nbt1404","article-title":"The impact of target site accessibility on the design of effective siRNAs","volume":"26","author":"Tafer","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2022.12.008_bib23","first-page":"401903","article-title":"Sonic Hedgehog signaling drives proliferation of synoviocytes in rheumatoid arthritis: a possible novel therapeutic target","volume":"2014","author":"Wang","year":"2014","journal-title":"J.\u00a0Immunol. Res."},{"key":"10.1016\/j.omtn.2022.12.008_bib24","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/cmi.2015.67","article-title":"Inhibition of smoothened decreases proliferation of synoviocytes in rheumatoid arthritis","volume":"14","author":"Zhu","year":"2017","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.omtn.2022.12.008_bib25","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.3389\/fimmu.2018.02847","article-title":"Sonic Hedgehog signaling pathway mediates proliferation and migration of fibroblast-like synoviocytes in rheumatoid arthritis via MAPK\/ERK signaling pathway","volume":"9","author":"Liu","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtn.2022.12.008_bib26","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.3389\/fimmu.2020.01300","article-title":"Sonic Hedgehog regulates proliferation, migration and invasion of synoviocytes in rheumatoid arthritis via JNK signaling","volume":"11","author":"Zhu","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtn.2022.12.008_bib27","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1111\/jphp.12379","article-title":"Inhibition of Hedgehog signal pathway by cyclopamine attenuates inflammation and articular cartilage damage in rats with adjuvant-induced arthritis","volume":"67","author":"Li","year":"2015","journal-title":"J.\u00a0Pharm. Pharmacol."},{"key":"10.1016\/j.omtn.2022.12.008_bib28","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/13543776.2020.1730327","article-title":"Hedgehog signaling pathway inhibitors: an updated patent review (2015-present)","volume":"30","author":"Quaglio","year":"2020","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.omtn.2022.12.008_bib29","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.jaad.2018.07.004","article-title":"Efficacy, safety, and comparison of sonic Hedgehog inhibitors in basal cell carcinomas: a systematic review and meta-analysis","volume":"79","author":"Xie","year":"2018","journal-title":"J.\u00a0Am. Acad. Dermatol."},{"key":"10.1016\/j.omtn.2022.12.008_bib30","doi-asserted-by":"crossref","first-page":"117302","DOI":"10.1016\/j.lfs.2020.117302","article-title":"Analysis of vismodegib resistance in D473G and W535L mutants of SMO receptor and design of novel drug derivatives using molecular dynamics simulations","volume":"244","author":"Liao","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.omtn.2022.12.008_bib31","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.molonc.2014.09.003","article-title":"Smoothened (SMO) receptor mutations dictate resistance to vismodegib in basal cell carcinoma","volume":"9","author":"Pricl","year":"2015","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.omtn.2022.12.008_bib32","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1158\/0008-5472.CAN-10-2876","article-title":"Small molecule inhibition of GDC-0449 refractory smoothened mutants and downstream mechanisms of drug resistance","volume":"71","author":"Dijkgraaf","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.omtn.2022.12.008_bib33","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1093\/nar\/gki193","article-title":"Locked nucleic acid (LNA) mediated improvements in siRNA stability and functionality","volume":"33","author":"Elm\u00e9n","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2022.12.008_bib34","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.bbrc.2006.02.049","article-title":"Chemical modification of siRNAs to improve serum stability without loss of efficacy","volume":"342","author":"Choung","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.omtn.2022.12.008_bib35","doi-asserted-by":"crossref","first-page":"10905","DOI":"10.1093\/nar\/gky745","article-title":"Functional features defining the efficacy of cholesterol-conjugated, self-deliverable, chemically modified siRNAs","volume":"46","author":"Shmushkovich","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2022.12.008_bib36","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1093\/nar\/gkp106","article-title":"A large-scale chemical modification screen identifies design rules to generate siRNAs with high activity, high stability and low toxicity","volume":"37","author":"Bramsen","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2022.12.008_bib37","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s00018-017-2656-0","article-title":"Evaluation and control of miRNA-like off-target repression for RNA interference","volume":"75","author":"Seok","year":"2018","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.omtn.2022.12.008_bib38","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s11658-019-0196-3","article-title":"Editorial focus: understanding off-target effects as the key to successful RNAi therapy","volume":"24","author":"Bartoszewski","year":"2019","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.omtn.2022.12.008_bib39","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1093\/nar\/gki324","article-title":"A computational study of off-target effects of RNA interference","volume":"33","author":"Qiu","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2022.12.008_bib40","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nrg3978","article-title":"Knocking down disease: a progress report on siRNA therapeutics","volume":"16","author":"Wittrup","year":"2015","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.omtn.2022.12.008_bib41","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nrd4685","article-title":"Clinical experiences with systemically administered siRNA-based therapeutics in cancer","volume":"14","author":"Zuckerman","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"issue":"Pt 3","key":"10.1016\/j.omtn.2022.12.008_bib42","first-page":"503","article-title":"The joint capsule: structure, composition, ageing and disease","volume":"184","author":"Ralphs","year":"1994","journal-title":"J.\u00a0Anat."},{"key":"10.1016\/j.omtn.2022.12.008_bib43","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1136\/annrheumdis-2021-220266","article-title":"EULAR recommendations for intra-articular therapies","volume":"80","author":"Uson","year":"2021","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.omtn.2022.12.008_bib44","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1136\/annrheumdis-2016-209830","article-title":"Possibilities for preventive treatment in rheumatoid arthritis? Lessons from experimental animal models of arthritis: a systematic literature review and meta-analysis","volume":"76","author":"Dekkers","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.omtn.2022.12.008_bib45","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/nprot.2007.173","article-title":"Collagen-induced arthritis","volume":"2","author":"Brand","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.omtn.2022.12.008_bib46","doi-asserted-by":"crossref","first-page":"R123","DOI":"10.1186\/ar2331","article-title":"Gait analysis in a murine model of collagen-induced arthritis","volume":"9","author":"Vincelette","year":"2007","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.omtn.2022.12.008_bib47","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/rheumatology\/keab388","article-title":"Clinical and biomechanical factors associated with falls and rheumatoid arthritis: baseline cohort with longitudinal nested case-control study","volume":"61","author":"Smith","year":"2022","journal-title":"Rheumatology"},{"key":"10.1016\/j.omtn.2022.12.008_bib48","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1136\/annrheumdis-2011-200343","article-title":"The relationship between joint damage and functional disability in rheumatoid arthritis: a systematic review","volume":"71","author":"Bombardier","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.omtn.2022.12.008_bib49","doi-asserted-by":"crossref","first-page":"873","DOI":"10.2174\/156652409789105570","article-title":"Hedgehog target genes: mechanisms of carcinogenesis induced by aberrant Hedgehog signaling activation","volume":"9","author":"Katoh","year":"2009","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.omtn.2022.12.008_bib50","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/nm.3389","article-title":"Unraveling the therapeutic potential of the Hedgehog pathway in cancer","volume":"19","author":"Amakye","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtn.2022.12.008_bib51","doi-asserted-by":"crossref","first-page":"3830212","DOI":"10.1155\/2020\/3830212","article-title":"Molecular and cellular pathways contributing to joint damage in rheumatoid arthritis","volume":"2020","author":"Fang","year":"2020","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.omtn.2022.12.008_bib52","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/BOR.0000000000000148","article-title":"The role of the synovial fibroblast in rheumatoid arthritis pathogenesis","volume":"27","author":"Turner","year":"2015","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.omtn.2022.12.008_bib53","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.omtn.2022.12.008_bib54","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/cgt.2016.4","article-title":"Precise and efficient siRNA design: a key point in competent gene silencing","volume":"23","author":"Fakhr","year":"2016","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.omtn.2022.12.008_bib55","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/nbt936","article-title":"Rational siRNA design for RNA interference","volume":"22","author":"Reynolds","year":"2004","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2022.12.008_bib56","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1038\/nprot.2007.278","article-title":"A protocol for designing siRNAs with high functionality and specificity","volume":"2","author":"Birmingham","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.omtn.2022.12.008_bib57","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1758-907X-1-16","article-title":"In\u00a0vivo quantification of formulated and chemically modified small interfering RNA by heating-in-Triton quantitative reverse transcription polymerase chain reaction (HIT qRT-PCR)","volume":"1","author":"Landesman","year":"2010","journal-title":"Silence"},{"key":"10.1016\/j.omtn.2022.12.008_bib58","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1136\/annrheumdis-2020-219247","article-title":"'SMASH' recommendations for standardised microscopic arthritis scoring of histological sections from inflammatory arthritis animal models","volume":"80","author":"Hayer","year":"2021","journal-title":"Ann. Rheum. Dis."}],"container-title":["Molecular Therapy - Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253122003298?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253122003298?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T01:35:49Z","timestamp":1761874549000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253122003298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":58,"alternative-id":["S2162253122003298"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2022.12.008","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chemically modified small interfering RNA targeting Hedgehog signaling pathway for rheumatoid arthritis therapy","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2022.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors.","name":"copyright","label":"Copyright"}]}}